I wouldn't be surprised if we don't go under 6 after the PR. That doesn't mean that I am not hopeful for a lift in SP but just saying I wouldn't be shocked if it went south the day of.
Look how everyone sold the news after FDA approval.
No one who follows this board should be surprised with approval.
That is why I think holding a CC post announcement is critical to build confidence in AMRN. Where a very confident, clear, practical, efficient plan for roll out in Europe is discussed where JT expands on what has already been shared.
We've got to get the analysts on board that we can sell in Europe. I hope he would also use this as an opportunity to expand on US sales and build confidence in the investment community that we will start substantially expanding sales as Summer rolls around.
If no one believes we can sell in Europe (or the US) then the approval will be mute for the SP IMO.
News 
Market Data 
Discover 
